http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102020002836-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1377e50824c9c7d53fba5067ff014e2 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 |
| filingDate | 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_487f7a82cdf62f6cf63ebb3dc5c03723 |
| publicationDate | 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102020002836-A1 |
| titleOfInvention | Pharmaceutical and therapeutic use of S-acetylglutathione and its enzymes against viruses and the coronavirus (Covid 19) |
| abstract | The patent describes the direct action of the precursor molecule S-acetylglutathione (drawing no. 1) against viruses with its co-enzymes glutathione and glutathione peroxidase (drawing 2). This patent is also intended to show that SAG and G-SH and G-SH Px1 can be an important therapy against viruses and also against COVID 19. A healthy cell, i.e. with an optimal redox potential, can minimize viruses and slow down virus replication, in a non-specific manner. Abbreviations: SAG = S-acetylglutathione G-SH = reduced glutathione G-SH Px1 = glutathione peroxidase Main drawing = drawing 1 |
| priorityDate | 2020-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 81.